CSIRO to develop medicinal cannabis products

March 1st, 2021

@AuManufacturing, Other, 25/02/2021, Peter Roberts
CSIRO is to develop new medicinal cannabis products to help people with a variety of conditions including multiple sclerosis and chronic pain. Under a new licence, CSIRO will partner with local manufacturers to drive the development of new cannabis therapeutics, a market projected to be worth US$44 billion by 2024.

Read more: https://www.aumanufacturing.com.au/csiro-to-develop-medicinal-cannabis-products